Fulcrum Therapeutics Price Chart
Fulcrum Therapeutics Volume Chart
Fulcrum Therapeutics Market Segments
Premarket
+0.00(+0.00%)
| Open | $3.75 |
|---|---|
| Close | $3.75 |
| Low | $3.75 |
| Low Change | 0.00 (0.00%) |
| High | $3.75 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 604 |
| Dollar Volume | $2.27K |
Overnight
*No Trades in Segment
After Hours Yesterday
-0.12(-3.18%)
| Open | $3.77 |
|---|---|
| Close | $3.65 |
| Low | $3.65 |
| Low Change | -0.12 (-3.18%) |
| High | $3.77 |
| High Change | +0.00 (+0.00%) |
| Range | $0.12 |
| Volume | 195.397K |
| Dollar Volume | $713.20K |
Regular Trading Hours Yesterday
+0.08(+2.17%)
| Open | $3.69 |
|---|---|
| Close | $3.77 |
| Low | $3.63 |
| Low Change | -0.06 (-1.63%) |
| High | $3.89 |
| High Change | +0.20 (+5.28%) |
| Range | $0.26 |
| Volume | 2.661M |
| Dollar Volume | $10.03M |
Premarket Yesterday
*No Trades in Segment
Fulcrum Therapeutics News
3 weeks agoinvesting.comWhy is Fulcrum Therapeutics stock collapsing today?
3 weeks agobenzinga.comFULC Stock Crashes After Hours: What Investors Need To Know
- 3 weeks agoinvesting.com
Why is Fulcrum Therapeutics stock collapsing after-hours?
- 3 weeks agoinvesting.com
After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
- 3 weeks agoinvesting.com
Fulcrum Therapeutics stock plunges 30% on program discontinuation
- 4 months agoinvesting.com
Fulcrum Therapeutics stock tumbles despite trial results
Fulcrum Therapeutics Top Trades
Fulcrum Therapeutics's top trade so far today returned +0.00%, while the top short trade returned 0.00%.
Fulcrum Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $3.58 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.54 |
| 20 Day Moving Average (SMA20) | $4.45 |
| 50 Day Moving Average (SMA50) | $6.15 |
| 100 Day Moving Average (SMA100) | $7.43 |
| 200 Day Moving Average (SMA200) | $8.55 |
Fulcrum Therapeutics Statistics
| Average Volume (30 Days) | 3.24M |
|---|---|
| P/E Ratio (Current) | -3.25 |
| EPS (Current) | -$1.14 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$63.88M |
| Cash Ratio | 5.10 |
| Current Ratio | 34.33 |
| Quick Ratio | 34.33 |
| Debt to Equity | 0.00 |
| Enterprise Value | $196.28M |
| EV to EBITDA | -2.30 |
| EV to Sales | — |
| Price to Book | 0.74 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.22% |
| Return on Equity | -0.23% |
Fulcrum Therapeutics Stock Splits
There have been no stock splits for Fulcrum Therapeutics (FULC).
Fulcrum Therapeutics Dividends
There have been no dividends for Fulcrum Therapeutics (FULC).